Purchase Order HHSN272201600725P
- Not listed
- This is a federal contract award to Miltenyi Biotec, Inc., a biotechnology company that provides specialized scientific instruments, reagents, and services to government agencies. The award, valued at $4,563.50, is for the acquisition of antibodies from Miltenyi Biotec. The contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), and is a firm fixed-price purchase order with no set-aside designation. Miltenyi...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract is valued at $4,058.00 and provides for the delivery of Miltenyi Biotec's dissociation kits, buffers, and antibodies. This award is not associated with a set-aside designation....
- This federal contract award to Miltenyi Biotec, Inc. is a Firm Fixed Price Purchase Order from the National Institute of Allergy and Infectious Diseases (NIAID) for the supply of a custom reagent, CD45 - MB4-6D6, NHP - PURE (UNCONJUGATED)(10 MG), with a ceiling value of $7,021.00. The award was made on November 3, 2015, with a completion date of November 29, 2015. This appears to be a standalone contract award, as there is no indication of a set-aside or larger contract vehicle. Miltenyi...
- This firm-fixed-price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a global biotechnology company, for the delivery of a cell dissociator and cell separator. The award, valued at $58,517.50, was made without a set-aside designation and has an ultimate completion date of September 30, 2017. Miltenyi Biotec is a well-established federal contractor,...
- This is a $8,379.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company, for the supply of biomaterials. The award is not designated as a set-aside contract. Miltenyi Biotec is a prime contractor that frequently supports federal biomedical research programs with its specialized cell separation, analysis, and processing technologies, including flow cytometers, cell sorters, and...
- This is a $3,641 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract does not have a set-aside designation. The award supports NIAID's biomedical research programs, particularly in areas such as cancer, immunology, and infectious diseases. Key deliverables include the supply of FDA-approved,...
- This is a $14,781 fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The contract is for the supply of specialized biotechnology products and services, including cell separation and analysis equipment, reagents, and consumables. Miltenyi Biotec is a global biotechnology company that frequently provides equipment and supplies to federal agencies like the NIH,...
- This $4,881 firm fixed-price purchase order was awarded to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services to support biomedical research and cell therapy development. The award is for the delivery of lab equipment to the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH). Miltenyi Biotec has extensive experience as a prime contractor for federal...
- This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, is a one-time maintenance purchase order valued at $3,425.00. The contract was issued by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), and did not have a set-aside designation. Miltenyi Biotec is an experienced federal contractor, having previously received awards from various agencies including the NIH, Department of Veterans Affairs,...
- This federal contract award to Miltenyi Biotec, Inc., a global biotechnology company, was made by the National Institutes of Health (NIH). The $12,867 firm fixed-price purchase order covers the supply of Miltenyi antibodies, cell separation starter kits, and related consumables. Miltenyi Biotec has an extensive history as a prime contractor for numerous federal agencies, including the NIH, Department of Veterans Affairs, and Department of Defense, providing a range of specialized laboratory...
This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. The contract is for the delivery of 20 mg of the CD45 MB4-6D6 antibody product in 5 x 1 mL aliquots at a concentration of 4 mg/mL. The total ceiling value of the award is $12,851.00 with a period of performance through June 30, 2016. This contract was awarded without any set-aside designation. Miltenyi Biotec is a global biotechnology company that provides specialized instruments, reagents, and services to support biomedical research, cell therapy development, and clinical translation. As a federal contractor, they have extensive experience supplying a range of cell separation, analysis, and processing technologies to government agencies like the NIH, VA, and DoD. This specific award supports biomedical research, likely related to areas such as cancer, immunology, or infectious diseases. In addition to this purchase order, Miltenyi Biotec holds a significant $2.3 million indefinite delivery contract (IDC) with the NIH Clinical Center, awarded in June 2023. This single-award vehicle provides for the supply of proprietary CliniMACS cell isolation reagents and consumables through September 2024, with options to extend to 2027, supporting the NIH's cell processing and manufacturing capabilities for investigational cell therapy products used in clinical trials.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.9k | 5/31/16 |